Index RUT
P/E -
EPS (ttm) -12.02
Insider Own 40.57%
Shs Outstand 9.32M
Perf Week 10.10%
Market Cap 468.35M
Forward P/E -
EPS next Y -9.74
Insider Trans -0.27%
Shs Float 5.57M
Perf Month -14.78%
Income -101.60M
PEG -
EPS next Q -2.57
Inst Own 59.06%
Short Float 5.39%
Perf Quarter 14.73%
Sales 0.00M
P/S -
EPS this Y 82.53%
Inst Trans 2.69%
Short Ratio 2.20
Perf Half Y 12.69%
Book/sh 19.28
P/B 2.43
EPS next Y -5.10%
ROA -70.10%
Short Interest 0.30M
Perf Year -4.97%
Cash/sh 13.89
P/C 3.38
EPS next 5Y -
ROE -93.91%
52W Range 30.00 - 98.00
Perf YTD -2.19%
Dividend Est. -
P/FCF -
EPS past 5Y -11.67%
ROI -45.89%
52W High -52.16%
Beta 3.66
Dividend TTM -
Quick Ratio 11.23
Sales past 5Y -26.84%
Gross Margin -
52W Low 56.24%
ATR (14) 6.51
Dividend Ex-Date -
Current Ratio 11.23
EPS Y/Y TTM 85.54%
Oper. Margin -
RSI (14) 46.11
Volatility 14.43% 12.73%
Employees 101
Debt/Eq 0.23
Sales Y/Y TTM -
Profit Margin -
Recom 1.00
Target Price 133.83
Option/Short No / Yes
LT Debt/Eq 0.23
EPS Q/Q 85.65%
Payout -
Rel Volume 0.69
Prev Close 43.96
Sales Surprise -
EPS Surprise 10.56%
Sales Q/Q -
Earnings Nov 12 AMC
Avg Volume 136.71K
Price 46.88
SMA20 -2.14%
SMA50 -13.77%
SMA200 -8.43%
Trades
Volume 93,980
Change 6.64%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-21-24 Initiated
Raymond James
Strong Buy
$153
Aug-14-24 Initiated
William Blair
Outperform
$180
Mar-28-24 Reiterated
H.C. Wainwright
Buy
$100 → $115
Feb-27-24 Initiated
BMO Capital Markets
Outperform
$120
Dec-04-23 Initiated
H.C. Wainwright
Buy
$100
Nov-29-23 Initiated
RBC Capital Mkts
Outperform
$70
Nov-10-23 Initiated
Piper Sandler
Overweight
$180
Feb-15-23 Downgrade
Chardan Capital Markets
Buy → Neutral
Feb-13-23 Downgrade
Cowen
Outperform → Market Perform
Sep-22-21 Downgrade
Goldman
Buy → Neutral
$12 → $9
Jan-27-21 Upgrade
JP Morgan
Neutral → Overweight
$56
Dec-22-20 Initiated
B. Riley Securities
Buy
$79
Jul-14-20 Initiated
Oppenheimer
Outperform
$36
May-18-20 Downgrade
JP Morgan
Overweight → Neutral
$27
Oct-28-19 Initiated
JP Morgan
Overweight
$25
Oct-28-19 Initiated
Goldman
Buy
$30
Oct-28-19 Initiated
Cowen
Outperform
Show Previous Ratings
Dec-10-24 08:00AM
Nov-21-24 04:01PM
07:30AM
Nov-14-24 08:00AM
Nov-12-24 04:05PM
(GlobeNewswire) -11.37%
-15.55%
07:25AM
Loading…
Nov-04-24 07:25AM
Oct-21-24 04:15PM
(Investor's Business Daily) -5.22%
-7.70%
Oct-16-24 04:20PM
(Investor's Business Daily) +93.66%
Sep-30-24 08:00AM
Sep-16-24 08:00AM
Sep-10-24 08:00AM
Aug-28-24 08:00AM
Aug-27-24 08:00AM
Aug-13-24 04:01PM
Jul-01-24 08:00AM
12:53PM
Loading…
Jun-25-24 12:53PM
May-30-24 04:01PM
May-20-24 02:30PM
May-14-24 10:55PM
04:01PM
Apr-18-24 08:30AM
Apr-01-24 04:01PM
Mar-26-24 04:01PM
Feb-27-24 09:55AM
08:00AM
Feb-09-24 09:55AM
Jan-18-24 08:00AM
Jan-04-24 08:00AM
Dec-07-23 08:00AM
Nov-28-23 08:00AM
03:31PM
Loading…
Nov-03-23 03:31PM
12:19PM
Aug-10-23 04:01PM
Jul-17-23 11:59AM
Jul-14-23 11:22AM
06:30AM
May-12-23 04:01PM
Mar-10-23 07:30AM
Feb-27-23 07:30AM
Feb-13-23 01:55PM
(American City Business Journals) -80.54%
11:17AM
08:05AM
Dec-19-22 07:30AM
Dec-15-22 07:30AM
Nov-17-22 07:30AM
Nov-08-22 04:05PM
Oct-12-22 07:30AM
Aug-30-22 07:30AM
Aug-09-22 04:05PM
(Business Wire) -11.11%
+9.00%
Jun-24-22 09:03AM
May-25-22 12:00PM
May-18-22 07:30AM
May-04-22 04:30PM
Apr-22-22 07:30AM
Apr-08-22 05:00PM
Mar-15-22 07:30AM
Mar-10-22 06:35PM
Feb-28-22 07:30AM
Jan-14-22 05:43AM
Jan-04-22 07:30AM
Dec-28-21 02:38AM
Dec-09-21 01:18PM
07:30AM
Nov-30-21 05:53AM
Nov-15-21 12:25PM
07:30AM
Nov-09-21 07:30AM
Nov-08-21 03:00PM
Oct-27-21 07:30AM
Oct-21-21 07:30AM
Oct-01-21 08:23AM
Sep-22-21 11:18AM
07:30AM
Sep-08-21 07:30AM
Aug-30-21 05:10PM
Aug-12-21 04:06PM
08:45AM
07:30AM
Aug-04-21 03:00PM
Aug-02-21 03:05PM
02:30PM
12:30PM
12:30PM
11:00AM
10:00AM
09:16AM
09:09AM
05:50AM
03:27AM
Aug-01-21 10:38AM
06:36AM
Jul-30-21 08:49PM
07:19PM
07:10PM
05:15PM
02:57PM
01:30PM
12:40PM
11:30AM
11:30AM
Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Agarwal Vineet Chief Financial Officer Nov 11 '24 Option Exercise 11.68 800 9,344 800 Nov 12 07:40 PM Agarwal Vineet Chief Financial Officer Nov 11 '24 Sale 70.00 800 56,000 0 Nov 12 07:40 PM Agarwal Vineet Officer Nov 11 '24 Proposed Sale 70.00 800 56,000 Nov 12 08:28 AM Agarwal Vineet Chief Financial Officer Oct 17 '24 Option Exercise 11.99 10,216 122,468 10,216 Oct 18 07:43 PM Agarwal Vineet Chief Financial Officer Oct 17 '24 Sale 78.26 10,216 799,527 0 Oct 18 07:43 PM Agarwal Vineet Officer Oct 17 '24 Proposed Sale 78.26 10,216 799,527 Oct 17 04:22 PM Colletti Steve Former Officer Oct 16 '24 Proposed Sale 88.67 13,821 1,225,450 Oct 16 01:05 PM Colletti Steve Former Officer Aug 30 '24 Proposed Sale 49.24 10,303 507,326 Aug 30 05:28 PM New Enterprise Associates 17, 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM BASKETT FOREST 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Florence Anthony A. Jr. 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Walker Paul Edward 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Chang Carmen 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Mathers Edward T 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Yang Rick 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Makhzoumi Mohamad 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM SANDELL SCOTT D 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Atlas Venture Opportunity Fund 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 195,074 Apr 23 05:23 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite